Abstract | BACKGROUND AND AIMS: APPROACH AND RESULTS: Here, we tested an approach based on the design, synthesis, and validation of a family of UDCA synthetic conjugates with selective HDAC6i capacity (UDCA-HDAC6i). Four UDCA-HDAC6i conjugates presented selective HDAC6i activity, UDCA-HDAC6i #1 being the most promising candidate. UDCA orientation within the UDCA-HDAC6i structure was determinant for HDAC6i activity and selectivity. Treatment of polycystic rats with UDCA-HDAC6i #1 reduced their hepatomegaly and cystogenesis, increased UDCA concentration, and inhibited HDAC6 activity in liver. In cystic cholangiocytes UDCA-HDAC6i #1 restored primary cilium length and exhibited potent antiproliferative activity. UDCA-HDAC6i #1 was actively transported into cells through BA and organic cation transporters. CONCLUSIONS: These UDCA-HDAC6i conjugates open a therapeutic avenue for PLDs.
|
Authors | Francisco J Caballero-Camino, Ivan Rivilla, Elisa Herraez, Oscar Briz, Alvaro Santos-Laso, Laura Izquierdo-Sanchez, Pui Y Lee-Law, Pedro M Rodrigues, Patricia Munoz-Garrido, Sujeong Jin, Estanislao Peixoto, Seth Richard, Sergio A Gradilone, Maria J Perugorria, Manel Esteller, Luis Bujanda, Jose J G Marin, Jesus M Banales, Fernando P Cossío |
Journal | Hepatology (Baltimore, Md.)
(Hepatology)
Vol. 73
Issue 1
Pg. 186-203
(01 2021)
ISSN: 1527-3350 [Electronic] United States |
PMID | 32145077
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases. |
Chemical References |
- Bile Acids and Salts
- Synthetic Drugs
- Ursodeoxycholic Acid
- Histone Deacetylase 6
|
Topics |
- Animals
- Apoptosis
- Bile Acids and Salts
(metabolism)
- Bile Ducts
(metabolism, pathology)
- Cell Proliferation
(drug effects)
- Cysts
(drug therapy, metabolism, pathology)
- Disease Models, Animal
- Histone Deacetylase 6
(antagonists & inhibitors)
- Liver
(drug effects, metabolism, pathology)
- Liver Diseases
(drug therapy, metabolism, pathology)
- Random Allocation
- Rats
- Synthetic Drugs
(pharmacology)
- Ursodeoxycholic Acid
(pharmacology, therapeutic use)
|